Table 2
Leapfrog CPOE Evaluation Test Clinical Decision Support Categories
| Therapeutic Duplication | Therapeutic overlap with another new or active order; may be same drug, same drug class, or components of combination products. |
| Single and Cumulative Dose Limits | Specified dose that exceeds recommended dose ranges; will result in a cumulative dose that exceeds recommended ranges; can also include does limits for each component of a combination product. |
| Allergies and Cross Allergies | Allergy has been documented or allergy to other drug in same category exists. |
| Contraindicated Route of Administration | Order specifying a route of administration that is not appropriate for the identified medication. |
| Drug–Drug and Drug–Food Interactions | Results in known, dangerous interaction when administered together with a different medication or results in an interaction in combination with a drug or food group. |
| Contraindications/Dose Limits Based on Patient Diagnosis | Contraindication based on patient diagnosis or diagnosis affects recommended dosing. |
| Contraindications/Dose Limits Based on Patient Age or Weight | Contraindication based on age or weight. |
| Contraindications/Dose Limits Based on Laboratory Studies | Contraindication based on laboratory studies or for which laboratory studies must be considered for dosing. |
| Contraindications/Dose Limits Based on Radiology Studies | Contraindication for this patient based on interaction with contrast medium (in ordered radiology study). |
| Corollary | Intervention that requires an associated or secondary order to meet the standard of care (prompt to order drug levels during medication ordering). |
| Cost of Care | Test that duplicates a service within a timeframe in which there is typically minimal benefits from repeating the test. |
| Nuisance | Order with such a slight or inconsequential interaction that clinicians typically ignore the advice/prompt. |
